Skip to main content
Wacker Chemie AG logo

Wacker Chemie AG — Investor Relations & Filings

Ticker · WCH ISIN · DE000WCH8881 LEI · 0NURKC5Q3CJYZPPK5046 F Manufacturing
Open in API
Filings indexed 346 across all filing types
Latest filing 2020-12-09 M&A Activity
Country DE Germany
Listing F WCH

About Wacker Chemie AG

https://www.wacker.com/cms/en-de/home/h…

Wacker Chemie AG is a technology-focused chemical and biotechnology company that develops and manufactures a wide range of specialty products for global markets. The company's core activities are centered on silicone and polymer chemistry, providing advanced solutions for various sectors, including construction additives. A significant part of its business is Wacker Biotech, which operates as a full-service contract development and manufacturing organization (CDMO). This division specializes in the microbial-based production of therapeutic proteins, plasmid DNA (pDNA), messenger ribonucleic acid (mRNA), live microbial products (LMPs), and vaccines for the pharmaceutical and life sciences industries.

Recent filings

Filing Released Lang Actions
Wacker Chemie AG: WACKER Intends to Sell Its Stake in Siltronic to GlobalWafers
M&A Activity Classification · 100% confidence The document is a news release from Wacker Chemie AG, dated December 9, 2020, announcing a strategic decision: the intention to sell its entire stake in Siltronic AG to GlobalWafers Co., Ltd. This involves a voluntary takeover bid and an irrevocable undertaking. This type of announcement, detailing a major corporate transaction like a disposal or merger proposal, aligns best with the 'M&A Activity' category (TAR). It is not a standard regulatory filing like 10-K or IR, nor is it a simple earnings release or dividend notice. Since it explicitly discusses a takeover bid and disposal, TAR is the most precise fit.
2020-12-09 English
Wacker Chemie AG: WACKER Intends to Sell Its Stake in Siltronic to GlobalWafers
Delisting Announcement Classification · 99% confidence The document is an 'Ad-hoc' announcement dated December 9, 2020, disclosing insider information under MAR (Regulation (EU) No 596/2014). The core content is the intention of Wacker Chemie AG to sell its stake in Siltronic to GlobalWafers via a voluntary takeover bid. This announcement concerns a major corporate transaction involving the disposal of a significant holding, which falls under corporate actions related to capital structure or major investments/disposals. While it is a regulatory disclosure (MAR), the specific nature of the transaction—a proposed sale/takeover—is best classified under 'M&A Activity' (TAR) or potentially 'Capital/Financing Update' (CAP). Given the context of a takeover bid and the disposal of a major asset/subsidiary stake, TAR (Merger/Takeover Activity) is the most precise fit, as it describes the initiation of a transaction that could lead to a change in control or significant asset transfer. It is not a standard earnings release (ER), quarterly report (IR), or annual report (10-K). Since it is a specific announcement about a transaction, it is not the general fallback (RNS).
2020-12-09 English
Wacker Chemie AG: WACKER Supervisory Board Appoints Christian Hartel as the Company's Future CEO
Board/Management Information Classification · 100% confidence The document is a press release dated December 9, 2020, announcing significant changes in the senior management of Wacker Chemie AG. Specifically, it details the retirement of the current CEO, Rudolf Staudigl, and the appointment of Christian Hartel as the future CEO, effective after the next Annual Shareholders’ Meeting. This content directly relates to changes in the company's board of directors or senior management. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an earnings release (ER), a transcript (CT), or a formal regulatory report like a 10-K or IR.
2020-12-09 English
Wacker Chemie AG: WACKER Supervisory Board Appoints Christian Hartel as the Company's Future CEO
Board/Management Information Classification · 100% confidence The document is an 'Ad-hoc' announcement dated December 9, 2020, disclosing insider information under MAR (Article 17). The core content is the appointment of Christian Hartel as the future CEO and changes in the Executive Board structure. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information'. Therefore, the appropriate filing code is MANG.
2020-12-09 English
Wacker Chemie AG: WACKER is in Advanced, Near to Final Negotiations with GlobalWafers Regarding the Sale of its Stake in Siltronic
M&A Activity Classification · 100% confidence The document is an 'Ad-hoc' announcement dated November 29, 2020, disclosing inside information according to Article 17 MAR. The core content details advanced negotiations regarding the sale of Wacker Chemie AG's stake in Siltronic AG to GlobalWafers. This is a significant corporate action related to asset disposal and strategic decision-making, not a routine financial report (like 10-K or IR) or a standard earnings release (ER). It is a specific announcement about a potential transaction/disposal. While it mentions the Annual Report 2019 in the disclaimer, the primary purpose of this specific document is to announce the strategic negotiation/disposal. This fits best under Capital/Financing Update (CAP) as it concerns a major change in asset structure/capital, or potentially Regulatory Filings (RNS) as a general announcement. Given the specific nature of a major asset sale negotiation, 'CAP' is a strong candidate, but since it is an immediate, mandatory disclosure of a strategic decision/disposal under MAR, and not explicitly a financing round or capital change in the sense of issuing new shares, it is often categorized as a general regulatory announcement if a more specific category like M&A Activity (TAR) doesn't perfectly fit (TAR is usually for announced bids/mergers, not just negotiations for a stake sale). However, the keywords 'Strategic Company Decision/Disposal' strongly suggest a major corporate event. Since there is no specific category for 'Major Corporate Transaction Announcement' outside of M&A (TAR), and this is a mandatory disclosure of a significant event, it falls under the general regulatory announcement category (RNS) as the most appropriate fallback for significant, non-periodic, non-financial-result disclosures that don't fit other specific types like DIRS or DIV. It is a regulatory disclosure of a strategic event.
2020-11-29 English
Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV
M&A Activity Classification · 100% confidence The document is an 'Ad-hoc-Meldung' (Ad-hoc announcement) issued under Article 17 of the Market Abuse Regulation (MAR). It details a strategic company decision regarding the potential sale of a stake in Siltronic AG to GlobalWafers. Since this document concerns a merger/acquisition/disposal activity and is an official regulatory announcement of such an event, it falls under the M&A Activity category.
2020-11-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.